Short Squeeze Scan — 2026-07-12
Algolearn.AI July 12, 2026 3 min read 2 views
Squeeze 2026-07-12 · 0 top setups · 6 watchlist · 24 no signal
Automated daily scan of high-short-interest US stocks, scored against a 7-point short-squeeze checklist (the same warning signs that preceded the April 2026 CAR squeeze). Each top setup includes a defined-risk options idea built from live chain data. Not investment advice.
Top setups
No qualifying setups today.
Watchlist
| Ticker | Score | Summary |
|---|---|---|
| GRPN | 4/7 | GRPN has the highest short interest in the universe at 55.77% and an 11.28-day DTC — the structural squeeze fuel is real. Price has already rallied 62% off its Jun 10 low on what appears to be an emerging short-covering cycle. The August 12 earnings release is a 31-day binary catalyst with a low analyst bar ($-0.05 EPS). The setup is capped at 4/7 because borrow cost is negligible (0.54%), float lockup is only 48%, and options flow remains defensively put-skewed rather than call-accumulating. |
| HIMS | 3/7 | HIMS is a thesis-driven squeeze candidate rather than a structural one: DTC of 2.5, a 0.51% borrow rate, and a 210M-share float mean shorts face zero mechanical friction. However, extreme call skew (calls 8× more expensive than puts on the Jul-17 chain) and an FDA GLP-1 catalyst make this high-impact on a headline. The 31% run since Jun 5 confirms bulls are in control of the tape. Watch for any FDA announcement on compounding exemptions. |
| ACHC | 3/7 | ACHC cleared a 5.48-day DTC hurdle and rallied 28% on genuine turnaround signals: new CEO, activist engagement, and $300M CapEx cuts. The Jun 26 volume spike (15.65M shares, 6× normal) on an up day suggests institutional accumulation. Q2 earnings due in approximately 3 weeks are the next catalyst. The setup is capped at 3/7 because SI is below 40%, the options chain is illiquid with no call skew, and borrow costs are unconfirmed. |
| WGS | 3/7 | WGS (GeneDx genomic diagnostics) has a 15.61M-share float — small enough that a 6.9-day DTC becomes meaningful — paired with clear call skew (call IV 2.5× put IV) and 23% price momentum off a $51.80 base. The stock ran from $51 to $71 in two weeks before a modest pullback to $65. The setup lacks a confirmed near-term earnings catalyst and confirmed borrow pressure, keeping it at 3/7. A Q2 earnings date confirmation would upgrade this materially. |
| STIM | 3/7 | STIM has a 6.2–7.57-day DTC, 47% price recovery off the Jun 16 low, and an August 4 earnings catalyst (~23 days). The 236% YoY short interest growth signals persistent short conviction that could reverse violently on a positive earnings surprise. However, the options market disagrees sharply: put 25-delta IV is 8× call IV (skew +382%), signaling that sophisticated hedgers see more downside than upside risk heading into earnings. Monitor borrow rate and whether put skew compresses ahead of August 4. |
| XPOF | 3/7 | XPOF removed two major overhangs — an SEC investigation closed without action and preferred stock eliminated via $525M debt refinancing — and has rallied 20% in the scan window. If the universe SI of 37.11% is current, DTC of ~21 days would be the most extreme in the watchlist. Caution: the options market directly contradicts the squeeze thesis, with put IV 7.8× call IV (skew +681%); this flags that sophisticated market participants still see significant downside. Confirm the SI figure with the next FINRA settlement cycle before acting. |
No signal
BATL, AI, FLWS, SOUN, SPHR, SPRY, EVGO, LFVN, HTZ, LCID, FLNC, TTEC, RXRX, PCT, UONE, SERV, INDI, SATS, EOSE, XRX, WYFI, BETR, CRML, CRDF
Generated 2026-07-12 15:03 UTC by the AlgoLearn squeeze scanner. Defined-risk options ideas for informational purposes only — not investment advice.
https://pagerankcafe.com/pressRelease/blog/squeeze-scan-2026-07-12
